OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor
Ajit Regmi, Eitaro Aihara, Michael E. Christe, et al.
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1534-1549.e7
Open Access | Times Cited: 27
Ajit Regmi, Eitaro Aihara, Michael E. Christe, et al.
Cell Metabolism (2024) Vol. 36, Iss. 7, pp. 1534-1549.e7
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Glucose-dependent insulinotropic polypeptide (GIP)
Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, et al.
Molecular Metabolism (2025) Vol. 95, pp. 102118-102118
Open Access | Times Cited: 2
Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, et al.
Molecular Metabolism (2025) Vol. 95, pp. 102118-102118
Open Access | Times Cited: 2
The other side of the incretin story: GIPR signaling in energy homeostasis
Susana Castelo Branco Ramos Nakandakari, Andin Fosam, Rachel J. Perry
Cell Metabolism (2025) Vol. 37, Iss. 1, pp. 1-3
Closed Access | Times Cited: 1
Susana Castelo Branco Ramos Nakandakari, Andin Fosam, Rachel J. Perry
Cell Metabolism (2025) Vol. 37, Iss. 1, pp. 1-3
Closed Access | Times Cited: 1
Binding Kinetics, Bias, Receptor Internalization and Effects on Insulin Secretionin vitroandin vivoof a Novel GLP-1R/GIPR Dual Agonist, HISHS-2001
Yusman Manchanda, Ben Jones, Gaëlle Carrat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Yusman Manchanda, Ben Jones, Gaëlle Carrat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
Xinxin Yu, Shiuhwei Chen, Jan‐Bernd Funcke, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 7
Xinxin Yu, Shiuhwei Chen, Jan‐Bernd Funcke, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 7
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne, et al.
Gut (2024), pp. gutjnl-334023
Closed Access | Times Cited: 4
Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne, et al.
Gut (2024), pp. gutjnl-334023
Closed Access | Times Cited: 4
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis
Kieren J. Mather, Andrea Mari, Govinda J. Weerakkody, et al.
Diabetes Obesity and Metabolism (2025) Vol. 27, Iss. 3, pp. 1507-1514
Closed Access
Kieren J. Mather, Andrea Mari, Govinda J. Weerakkody, et al.
Diabetes Obesity and Metabolism (2025) Vol. 27, Iss. 3, pp. 1507-1514
Closed Access
A dietary intervention following incretin analog treatment restores adipose tissue functions in diet-induced obese mice
Jan Seuntjens, Jente De Gols, Bethan K. Davies, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Jan Seuntjens, Jente De Gols, Bethan K. Davies, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The physiological impact of an N‐terminal Halo‐tag on glucose‐dependent insulinotropic polypeptide receptor function in mice
Iona Davies, Yusman Manchanda, Kyle W. Sloop, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Iona Davies, Yusman Manchanda, Kyle W. Sloop, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Short‐term outcomes of switching from GLP ‐1 receptor agonists to tirzepatide in type 2 diabetes: A retrospective, observational study in clinical practice
Mari Matsushiro, Yuko Yamaguchi, Hitoshi Kuwata, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Mari Matsushiro, Yuko Yamaguchi, Hitoshi Kuwata, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
A 2-Years Comparative Analysis of Tirzepatide, Semaglutide, Qsymia, Contrave, and Phentermine on Ocular Health in Individuals with Obesity: A Propensity-Score Matched Cohort Study
Pen‐Hua Su, Yu‐Nan Huang, Jo-Ching Chen, et al.
Research Square (Research Square) (2025)
Closed Access
Pen‐Hua Su, Yu‐Nan Huang, Jo-Ching Chen, et al.
Research Square (Research Square) (2025)
Closed Access
The role of GIPR in food intake control
Paula-Peace James-Okoro, Jo E. Lewis, Fiona M. Gribble, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Paula-Peace James-Okoro, Jo E. Lewis, Fiona M. Gribble, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Development of a long-acting unbiased GIP receptor agonist for studies of GIP’s role in bone metabolism
Esther Karen Tordrup, Sarina Gadgaard, Johanne Agerlin Windeløv, et al.
Biochemical Pharmacology (2025), pp. 116893-116893
Closed Access
Esther Karen Tordrup, Sarina Gadgaard, Johanne Agerlin Windeløv, et al.
Biochemical Pharmacology (2025), pp. 116893-116893
Closed Access
Nicotinic acid increases adipose tissue dietary fatty acid trapping and reduces postprandial hepatic and cardiac fatty acid uptake in prediabetes
Émilie Montastier, Run Zhou Ye, Christophe Noll, et al.
European Journal of Pharmacology (2025), pp. 177563-177563
Open Access
Émilie Montastier, Run Zhou Ye, Christophe Noll, et al.
European Journal of Pharmacology (2025), pp. 177563-177563
Open Access
Adipocyte size distribution: Mathematical model of a tissue property
A. Dauger, Hédi Soula, Chloé Audebert
Mathematical Biosciences (2025), pp. 109433-109433
Open Access
A. Dauger, Hédi Soula, Chloé Audebert
Mathematical Biosciences (2025), pp. 109433-109433
Open Access
The Impact of Gastrointestinal Hormones on Human Adipose Tissue Function
Marcelina Radziszewska, Lucyna Ostrowska, Joanna Smarkusz-Zarzecka
Nutrients (2024) Vol. 16, Iss. 19, pp. 3245-3245
Open Access | Times Cited: 3
Marcelina Radziszewska, Lucyna Ostrowska, Joanna Smarkusz-Zarzecka
Nutrients (2024) Vol. 16, Iss. 19, pp. 3245-3245
Open Access | Times Cited: 3
Recent achievements and future directions of anti-obesity medications
Gerald Grandl, Aaron Novikoff, Xue Liu, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101100-101100
Open Access | Times Cited: 3
Gerald Grandl, Aaron Novikoff, Xue Liu, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101100-101100
Open Access | Times Cited: 3
The unexpected role of GIP in transforming obesity treatment
Inuk Zandvakili, Diego Pérez–Tilve
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 2
Inuk Zandvakili, Diego Pérez–Tilve
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 2
Tirzepatide’s innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health
Jingqi Yang, Yuncheng Gu, Huaigang Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Jingqi Yang, Yuncheng Gu, Huaigang Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
New insights into the regulation of GIPR signalling
Yusman Manchanda, Alejandra Tomás
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 571-572
Closed Access | Times Cited: 1
Yusman Manchanda, Alejandra Tomás
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 571-572
Closed Access | Times Cited: 1
Subcutaneous adipose tissue and skeletal muscle mitochondria following weight loss
Birgitta W. van der Kolk, Eija Pirinen, Rachel Nicoll, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 1
Birgitta W. van der Kolk, Eija Pirinen, Rachel Nicoll, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 1
Why does GLP ‐1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP ‐1 agonist alone in obese adults without type 2 diabetes?
Yuchen Jiang, Huijuan Zhu, Fengying Gong
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Yuchen Jiang, Huijuan Zhu, Fengying Gong
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Tirzepatide for overweight and obesity management
Malak Hamza, Dimitris Papamargaritis, Melanie J. Davies
Expert Opinion on Pharmacotherapy (2024), pp. 1-19
Open Access | Times Cited: 1
Malak Hamza, Dimitris Papamargaritis, Melanie J. Davies
Expert Opinion on Pharmacotherapy (2024), pp. 1-19
Open Access | Times Cited: 1
Targeting central pathway of Glucose‐Dependent Insulinotropic Polypeptide, Glucagon and Glucagon‐like Peptide‐1 for metabolic regulation in obesity and type 2 diabetes
Zhimin Xu, Song Wen, Meiyuan Dong, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Zhimin Xu, Song Wen, Meiyuan Dong, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Regulation of glucose and energy metabolism through actions of glucagon‐like peptide‐1 and glucose‐dependent insulinotropic polypeptide
Yasuo Zenimaru, Norio Harada
Journal of Diabetes Investigation (2024)
Open Access
Yasuo Zenimaru, Norio Harada
Journal of Diabetes Investigation (2024)
Open Access
Incretin-responsive human pancreatic adipose tissue organoids: a functional model for fatty pancreas research
Estela Lorza‐Gil, Olaf Strauß, Eckart Ziegler, et al.
Molecular Metabolism (2024) Vol. 91, pp. 102067-102067
Open Access
Estela Lorza‐Gil, Olaf Strauß, Eckart Ziegler, et al.
Molecular Metabolism (2024) Vol. 91, pp. 102067-102067
Open Access
